HONG KONG, Aug 22, 2022 – (ACN Newswire via SEAPRWire.com) – FTLife Insurance Company Limited (“FTLife”) is committed to helping its customers embrace the “Championing Spirit” in life. Today, it is announcing the launch of “Protect Starter” Critical Illness Protector (“Protect Starter”), which is aimed at young people and first-time insurance buyers. At an affordable... » read more
MELBOURNE, Sep 6, 2021 – (ACN Newswire via SEAPRWire.com) – A new treatment for schizophrenia in adults, Reagila(R) (cariprazine), was listed on the Pharmaceutical Benefits Scheme (PBS) on 1 September, providing patients with an additional treatment option. Approved in the US since 2015 and EU since 2017, Reagila is approved in over 52 countries for... » read more
– Adults living with schizophrenia will have access to a new treatment option with Reagila(R) (cariprazine) now reimbursed on the Pharmaceutical Benefits Scheme from 1 September, 2021.1 – There continues to be a significant, unmet need in treating schizophrenia. With a complex range of symptoms,2 treatment is not a “one size fits all”.3 This listing... » read more
One boy was found dead in a school. Another, with a history of mental health issues, has been remanded in prison. These tragic events two weeks ago have raised the nation’s awareness of mental illness in the young. They have also made me reflect on my work as a child psychiatrist for 20 years. For... » read more